Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Study of Oral Cyclophosphamide vs Doxorubicin in 65 Years or Older Patients With Advanced or Metastatic Soft Tissue Sarcoma: a UNICANCER/GERICO Multicenter Program

NCT04757337 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT04757337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04757337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Study of Oral Cyclophosphamide vs Doxorubicin in 65 Years or Older Patients With Advanced or Metastatic Soft Tissue Sarcoma: a UNICANCER/GERICO Multicenter Program
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Unknown status
Start date
June 18, 2021
Completion date
April 30, 2026
Enrollment
214 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced soft-tissue sarcoma, metastatic soft-tissue sarcoma